IL324797A - תכשירים חדשים לטיפול במחלות דלקתיות - Google Patents
תכשירים חדשים לטיפול במחלות דלקתיותInfo
- Publication number
- IL324797A IL324797A IL324797A IL32479725A IL324797A IL 324797 A IL324797 A IL 324797A IL 324797 A IL324797 A IL 324797A IL 32479725 A IL32479725 A IL 32479725A IL 324797 A IL324797 A IL 324797A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- disease
- inflammatory
- dfo
- metal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363468018P | 2023-05-22 | 2023-05-22 | |
| PCT/IB2024/054991 WO2024241250A2 (en) | 2023-05-22 | 2024-05-22 | Novel composition for treatment of inflammatory related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324797A true IL324797A (he) | 2026-01-01 |
Family
ID=93590398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324797A IL324797A (he) | 2023-05-22 | 2024-05-22 | תכשירים חדשים לטיפול במחלות דלקתיות |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4716530A2 (he) |
| JP (1) | JP2026521351A (he) |
| KR (1) | KR20260015873A (he) |
| CN (1) | CN121793956A (he) |
| AU (1) | AU2024275726A1 (he) |
| IL (1) | IL324797A (he) |
| MX (1) | MX2025013957A (he) |
| WO (1) | WO2024241250A2 (he) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ572226A (en) * | 2006-04-18 | 2011-05-27 | Ekr Therapeutics Inc | Pre-mixed, ready-to-use IV bolus compositions comprising nicardipine and methods of use |
| EP3189836B1 (en) * | 2009-08-19 | 2024-01-17 | Mordechai Chevion | Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| CA2971824A1 (en) * | 2014-12-22 | 2016-06-30 | Mordechai Chevion | New metal complexes of nocardamine and their use in pharmaceutical compositions |
-
2024
- 2024-05-22 IL IL324797A patent/IL324797A/he unknown
- 2024-05-22 CN CN202480048638.4A patent/CN121793956A/zh active Pending
- 2024-05-22 EP EP24810574.4A patent/EP4716530A2/en active Pending
- 2024-05-22 KR KR1020257042477A patent/KR20260015873A/ko active Pending
- 2024-05-22 AU AU2024275726A patent/AU2024275726A1/en active Pending
- 2024-05-22 JP JP2025568566A patent/JP2026521351A/ja active Pending
- 2024-05-22 WO PCT/IB2024/054991 patent/WO2024241250A2/en not_active Ceased
-
2025
- 2025-11-21 MX MX2025013957A patent/MX2025013957A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN121793956A (zh) | 2026-04-03 |
| WO2024241250A3 (en) | 2025-01-02 |
| JP2026521351A (ja) | 2026-06-30 |
| MX2025013957A (es) | 2026-03-02 |
| AU2024275726A1 (en) | 2025-12-11 |
| EP4716530A2 (en) | 2026-04-01 |
| KR20260015873A (ko) | 2026-02-03 |
| WO2024241250A2 (en) | 2024-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230181597A1 (en) | Metal complexes of nocardamine and their use in pharmaceutical compositions | |
| AU2016244189B2 (en) | Desferrioxamine-metal complexes for the treatment of immune-related disorders | |
| CN108884053A (zh) | 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法 | |
| JP6185575B2 (ja) | 皮膚炎症性疾患の治療方法 | |
| US10751316B2 (en) | Pharmaceutical composition for treating inflammation and pain | |
| JP2023089077A (ja) | N-アセチル又はn-アシルアミノ酸を含むアトピー又は痒み症治療用組成物 | |
| EP4716530A2 (en) | Novel composition for treatment of inflammatory related disorders | |
| EP2854785B1 (en) | Pharmaceutical composition for treating inflammation and pain | |
| AU2013274579B2 (en) | Compounds for treating inflammation and pain | |
| HK1238559A1 (en) | New metal complexes of nocardamine and their use in pharmaceutical compositions | |
| JP6189944B2 (ja) | 炎症及び疼痛を治療するための化合物 | |
| US20150306175A1 (en) | HSP For Use in Treatment for Imiquimod Related Side Effects |